A reduction in periprocedural acute hemodynamic decompensation events was offset by a tenfold higher rate of complications in a study reflecting first-in-human experience with the procedure.Read More
Nearly one-half of patients with ATTR-CM present with impaired left ventricular function, finds a large study in a racially and genetically diverse cohort.
Our experts profile the rationale behind — and potential future of — four interventional approaches to treating heart failure that are currently in clinical trials.
If the findings of a new retrospective study are confirmed in a randomized controlled trial, phosphodiesterase-5 inhibitors could become standard of care in this setting.
A new review of evidence is likely to shape guideline updates on an unaddressed but increasingly common issue in the care of heart transplant candidates and patients.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
An investigational procedure with percutaneous and minimally invasive surgical components promises a new treatment option for a heart failure population with limited alternatives.